- Home
- NATL vs BEAM Comparison
NATL vs BEAM Comparison
Compare NATL & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATL
- BEAM
- Stock Information
- Founded
- NATL 2023
- BEAM 2017
- Country
- NATL United States
- BEAM United States
- Employees
- NATL N/A
- BEAM N/A
- Industry
- NATL
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NATL
- BEAM Health Care
- Exchange
- NATL Nasdaq
- BEAM Nasdaq
- Market Cap
- NATL 2.0B
- BEAM 1.9B
- IPO Year
- NATL N/A
- BEAM 2020
- Fundamental
- Price
- NATL $34.08
- BEAM $24.70
- Analyst Decision
- NATL Buy
- BEAM Buy
- Analyst Count
- NATL 4
- BEAM 10
- Target Price
- NATL $35.50
- BEAM $47.67
- AVG Volume (30 Days)
- NATL 523.7K
- BEAM 1.1M
- Earning Date
- NATL 02-12-2025
- BEAM 02-25-2025
- Dividend Yield
- NATL N/A
- BEAM N/A
- EPS Growth
- NATL N/A
- BEAM N/A
- EPS
- NATL N/A
- BEAM N/A
- Revenue
- NATL $4,307,000,000.00
- BEAM $349,643,000.00
- Revenue This Year
- NATL $4.77
- BEAM N/A
- Revenue Next Year
- NATL $2.28
- BEAM $10.82
- P/E Ratio
- NATL N/A
- BEAM N/A
- Revenue Growth
- NATL 3.58
- BEAM 328.73
- 52 Week Low
- NATL $18.42
- BEAM $20.84
- 52 Week High
- NATL $35.50
- BEAM $49.50
- Technical
- Relative Strength Index (RSI)
- NATL 56.92
- BEAM 41.30
- Support Level
- NATL $33.31
- BEAM $24.96
- Resistance Level
- NATL $35.50
- BEAM $29.52
- Average True Range (ATR)
- NATL 1.20
- BEAM 1.64
- MACD
- NATL -0.09
- BEAM -0.51
- Stochastic Oscillator
- NATL 67.43
- BEAM 9.71
About NATL NCR Atleos Corporation
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a global customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. They manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications & Technology.
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.